Sichuan Biokin Pharmaceutical Co., Ltd. Class ASSE: 688506

Announcement on Voluntary Disclosure of Triggering of Milestone Payment Conditions by Wholly-owned Subsidiary Systimmune and Bristol-Myers Squibb for the Global Strategic Cooperation Agreement of iza-bren

· Issued by Sichuan Biokin Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Triggering of Milestone Payment Conditions by Wholly-owned Subsidiary Systimmune and Bristol-Myers Squibb for the Global Strategic Cooperation Agreement of iza-bren

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis